pyrophosphate has been researched along with Acute-Coronary-Syndrome* in 1 studies
1 other study(ies) available for pyrophosphate and Acute-Coronary-Syndrome
| Article | Year |
|---|---|
Ticagrelor inverse agonist activity at the P2Y
Ticagrelor is labelled as a reversible, direct-acting platelet P2Y. Studies were performed in human platelets, with P2Y. Initial studies revealed that a range of P2Y. Ticagrelor binding to P2Y Topics: Acute Coronary Syndrome; Adenosine; Adenosine Diphosphate; Blood Platelets; Diphosphates; Drug Inverse Agonism; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2024 |